Top Insights on the Global Heparin Market | Technavio

Technavio has published a new market research report on the global heparin market from 2018-2022. (Graphic: Business Wire)

LONDON--()--Market research firm Technavio has announced the release of their latest report on the global heparin market. This new report will provide expert market insights for the forecast period 2018-2022.

The new report will follow up on Technavio’s previous report, offering valuable insights into multiple sections, which are impacting the growth of the market across the globe. It will also provide detailed insights into the current competitive scenario, to provide new predictions for the forecast period.

The upgraded research report on the global heparin market is an integral part of Technavio’s cardiovascular and metabolic disorders portfolio. Technavio covers an extensive range of market research reports on the cardiovascular and metabolic disorders market, focusing on the development of innovative compounds for novel targets. Some of the topics covered include biologic therapeutics, peptide therapeutics, inflammatory bowel disease, and liver cirrhosis therapeutics.

This report is available at a USD 1,000 discount for a limited time only: View market snapshot before purchasing

Save more with Technavio. Buy 2 reports and get the third for FREE: View all Technavio’s current offers

Global opportunities for growth

Technavio’s previous report on the global heparin market projected that during 2015, EMEA dominated the market and accounted for a share of around 52%. The increasing adoption of new oral anticoagulants with better safety and efficacy profiles is driving the market. The side effects associated with the use of heparin products such as heparin-induced thrombocytopenia and the complications associated with bleeding could play a vital role in bolstering the adoption of oral anticoagulants such as dabigatran, apixaban, and rivaroxaban.

In the previous report, a senior research analyst at Technavio stated, “The wide use of heparin as an anti-inflammatory and antitumor agent will drive the prospects for market growth until the end of the forecast period. The anti-inflammatory activity of heparin, which prevents the metastatic spread of tumor cells is a new finding. Heparin exhibits this activity by neutralizing cationic mediators, inhibiting adhesion molecules, and inhibiting heparanase. Similarly, it has also been discovered that heparin can target P- and L-selectin and integrin activity and prevent cancer progression. The massive exploitation of heparin’s new therapeutic uses will result in market growth.”

Technavio’s new report on the global heparin market will evaluate the key geographical regions and their behavior over the past four years, introducing new data and observations and providing new predictions.

Looking for the latest information on the global heparin market? Request a free sample report

Technavio’s sample reports are free of charge and contain multiple sections of the report such as the market size and forecast, drivers, challenges, trends, and more.

Detailed analysis at your fingertips

Some of the topics that will be revisited in the new report include:

  • Market size and growth rate through 2022
  • Major factors driving the market growth
  • Competitive vendor landscape and market share analysis of the key players
  • Market opportunities and factors hindering growth

Technavio’s report on the global heparin market for the period 2018-2022 is available to order now and will be delivered within one week of purchase.


Technavio’s best deals of the month!

Technavio supports Health for All campaign on this World Health Day with 20% savings on all reports in the Health and Wellness category for the entire month.


Celebrate International Astronomy Day by indulging in a whopping 30% savings on all reports in the Space category. Offer valid from 16th April for a limited period.


About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

If you are interested in more information, please contact our media team at


Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200

Release Summary

Market research firm Technavio has announced the release of their latest report on the global heparin market for 2018-2022.


Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200